Contribution of Congenital Cytomegalovirus Infection to Permanent Hearing Loss in a Highly Seropositive Population: The Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study
- PMID: 31102409
- PMCID: PMC7931844
- DOI: 10.1093/cid/ciz413
Contribution of Congenital Cytomegalovirus Infection to Permanent Hearing Loss in a Highly Seropositive Population: The Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study
Abstract
Background: The exact contribution of congenital cytomegalovirus infection (cCMVI) to permanent hearing loss (HL) in highly seropositive populations is unknown. We determined the contribution of cCMVI to HL and estimated the effectiveness of newborn hearing screening (HS) in identifying neonates with CMV-related HL.
Methods: A total of 11 900 neonates born from a population with ≥97% maternal seroprevalence were screened for cCMVI and HL. cCMVI was confirmed by detection of CMV-DNA in saliva and urine at age <3 weeks.
Results: Overall, 68 (0.6%; 95% confidence interval [CI], 0.4-0.7) neonates were identified with cCMVI. Of the 91 (0.8%) newborns who failed the HS, 24 (26.4%) were confirmed with HL, including 7 (29.2%; 95% CI, 17.2-59.3) with cCMVI. Another newborn with cCMVI passed the HS but was confirmed with HL at age 21 days. Of the 62 neonates with cCMVI who underwent a complete hearing evaluation, 8 (12.9%; 95% CI, 6.7-23.4) had HL and most (7/8; 87.5%; 95% CI, 46.6-99.7) were identified by HS. The rate of CMV-related HL was 8 per 11 887 neonates (0.7 per 1000 live births). The prevalence ratio of HL among neonates with cCMVI compared to CMV-uninfected neonates was 89.5 (95% CI, 39.7-202.0). No late-onset cCMVI-related HL was detected during a median follow-up of 36 months.
Conclusions: cCMVI is an important cause of HL in childhood in all settings. Integrating targeted cCMVI screening among neonates who fail a HS could be a reasonable, cost-effective strategy to identify newborns with early-onset cCMVI-related HL.
Keywords: cytomegalovirus; CMV screening; HL; congenital infection; hearing screening.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Newborn Screening for Congenital Cytomegalovirus Infection…It Is Time.Clin Infect Dis. 2020 Mar 17;70(7):1385-1387. doi: 10.1093/cid/ciz415. Clin Infect Dis. 2020. PMID: 31107963 No abstract available.
Similar articles
-
Universal newborn screening for congenital cytomegalovirus infection: feasibility and relevance in a French type-III maternity cohort.BJOG. 2022 Jan;129(2):291-299. doi: 10.1111/1471-0528.16992. Epub 2021 Nov 23. BJOG. 2022. PMID: 34726316
-
Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.JAMA Netw Open. 2020 Dec 1;3(12):e2023949. doi: 10.1001/jamanetworkopen.2020.23949. JAMA Netw Open. 2020. PMID: 33275150 Free PMC article.
-
Brainstem auditory pathway maturation in term neonates with congenital cytomegalovirus infection: a cohort study.Eur J Pediatr. 2023 Jan;182(1):95-100. doi: 10.1007/s00431-022-04644-z. Epub 2022 Oct 7. Eur J Pediatr. 2023. PMID: 36207473
-
[Current Approaches in the Diagnosis and Management of Congenital Cytomegalovirus Infections and the Situation in Turkey].Mikrobiyol Bul. 2020 Jan;54(1):171-190. doi: 10.5578/mb.68978. Mikrobiyol Bul. 2020. PMID: 32050888 Review. Turkish.
-
Cytomegalovirus-A Risk Factor for Childhood Hearing Loss: A Systematic Review.Ear Hear. 2021 Nov-Dec 01;42(6):1447-1461. doi: 10.1097/AUD.0000000000001055. Ear Hear. 2021. PMID: 33928914
Cited by
-
Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant.Viruses. 2021 Dec 20;13(12):2551. doi: 10.3390/v13122551. Viruses. 2021. PMID: 34960820 Free PMC article.
-
Congenital Cytomegalovirus and Human Immunodeficiency Virus: Effects on Hearing, Speech and Language Development, and Clinical Outcomes in Children.Front Pediatr. 2021 Dec 16;9:771192. doi: 10.3389/fped.2021.771192. eCollection 2021. Front Pediatr. 2021. PMID: 34976894 Free PMC article. Review.
-
Brazilian Society of Otology task force - cochlear implant ‒ recommendations based on strength of evidence.Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101512. doi: 10.1016/j.bjorl.2024.101512. Epub 2024 Sep 16. Braz J Otorhinolaryngol. 2025. PMID: 39442262 Free PMC article. Review.
-
Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038. Int J Neonatal Screen. 2024. PMID: 38920845 Free PMC article. Review.
-
Congenital Co-infections Among HIV-Exposed Infants Born to Mothers on Antiretroviral Treatment in the United States.Front Pediatr. 2022 Jun 16;10:894627. doi: 10.3389/fped.2022.894627. eCollection 2022. Front Pediatr. 2022. PMID: 35783327 Free PMC article.
References
-
- Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol 2018; 42:149–54. - PubMed
-
- Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I. Hearing loss and congenital CMV infection: a systematic review. Pediatrics 2014; 134:972–82. - PubMed
-
- Meyer L, Sharon B, Huang TC, et al. . Analysis of archived newborn dried blood spots (DBS) identifies congenital cytomegalovirus as a major cause of unexplained pediatric sensorineural hearing loss. Am J Otolaryngol 2017; 38:565–70. - PubMed
-
- Barbi M, Binda S, Caroppo S, Ambrosetti U, Corbetta C, Sergi P. A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr Infect Dis J 2003; 22:39–42. - PubMed